Compliance and satisfaction with switching from an immediate-release to sustained-release formulation of valproate in people with epilepsy.

Abstract

OBJECTIVE The goal of our work was to assess compliance and patient satisfaction with switching from sodium valproate to Depakine Chrono in patients with epilepsy. METHODS Clinical, demographic, and behavioral details assessing compliance and satisfaction were collected using self-completion questionnaires at the time of inclusion in the study and 3… (More)

Topics

Cite this paper

@article{Doughty2003ComplianceAS, title={Compliance and satisfaction with switching from an immediate-release to sustained-release formulation of valproate in people with epilepsy.}, author={Julie Doughty and Gus A. Baker and Ann Jacoby and Virginie Lavaud}, journal={Epilepsy & behavior : E&B}, year={2003}, volume={4 6}, pages={710-6} }